Roivant Sciences Ltd. ROIV
NASDAQ · United States · Health Technology
$36.57+0.07 (+0.19%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q1 2026 | 2026-08-06 | -0.33 | -0.30 | -11.7% | $1.44M | -29.9% | +5.0%$34.60→$36.34 |
| Q4 2026 | 2026-05-20 | -0.32 | -0.35 | +8.6% | — | — | +9.5% |
| Q3 2026 | 2026-02-06 | -0.24 | -0.31 | +22.6% | — | — | +30.9%$21.14→$27.67 |
| Q2 2026 | 2025-11-10 | -0.28 | -0.30 | +6.7% | — | — | +1.4%$20.62→$20.90 |
| Q4 2025 | 2025-05-29 | -0.22 | -0.16 | -37.5% | — | — | — |
| Q3 2025 | 2025-02-10 | -0.20 | -0.24 | +16.7% | — | — | — |
| Q2 2025 | 2024-11-12 | -0.30 | -0.24 | -25.0% | — | — | — |
| Q4 2024 | 2024-05-30 | -0.23 | -0.29 | +20.7% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.